Patents by Inventor Horst Merkle

Horst Merkle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reminder, classification, and pattern identification systems and methods for handheld diabetes management devices
    Patent number: 9965587
    Abstract: A method includes: measuring a blood glucose (bG) level in a blood sample; storing the bG level and a time of receipt of the blood sample; storing a classification of the blood sample; in response to the receipt of the blood sample, selecting a group of stored bG levels having the classification of the blood sample and that were received within a predetermined period before receipt of the blood sample; calculating a bG evaluation parameter from the selected bG levels; evaluating the bG evaluation parameter in relation to first predetermined criteria, the first predetermined criteria including a first threshold indicative of a high bG level or a low bG level; selectively displaying an indication of recognition of a pattern in the selected bG levels when the bG evaluation parameter is greater than or less than the first threshold; and selectively removing the indication from the display.
    Type: Grant
    Filed: July 8, 2013
    Date of Patent: May 8, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Timothy N. Aykroyd, Amy C. Day, Paul J. Galley, Horst Merkle, Christen A. Rees, Michelle M. Stevens, Scott A. Wooldridge
  • REMINDER, CLASSIFICATION, AND PATTERN IDENTIFICATION SYSTEMS AND METHODS FOR HANDHELD DIABETES MANAGEMENT DEVICES
    Publication number: 20150012223
    Abstract: A method includes: measuring a blood glucose (bG) level in a blood sample; storing the bG level and a time of receipt of the blood sample; storing a classification of the blood sample; in response to the receipt of the blood sample, selecting a group of stored bG levels having the classification of the blood sample and that were received within a predetermined period before receipt of the blood sample; calculating a bG evaluation parameter from the selected bG levels; evaluating the bG evaluation parameter in relation to first predetermined criteria, the first predetermined criteria including a first threshold indicative of a high bG level or a low bG level; selectively displaying an indication of recognition of a pattern in the selected bG levels when the bG evaluation parameter is greater than or less than the first threshold; and selectively removing the indication from the display.
    Type: Application
    Filed: July 8, 2013
    Publication date: January 8, 2015
    Inventors: Timothy N. Aykroyd, Amy C. Day, Paul J. Galley, Horst Merkle, Christen A. Rees, Michelle M. Stevens, Scott A. Wooldridge